The Biggest Technology Failures of 2016
Stem-cell clinics
This year we learned the story of medical tourist Jim Gass, a corporate executive who hoped to have the results of a stroke healed with stem-cell treatments at a Mexican clinic and instead ended up with a strange, sticky mass in his spine. But you don’t need to go overseas for dodgy treatments never approved by the FDA. At least 351 U.S. businesses operating in a regulatory gray zone are promising that stem cells will treat everything from sports injuries to Alzheimer’s disease. “The clinics are doing an unapproved and for-profit gigantic human experiment,” according to stem cell scientist Paul Knoepfler.
Keep Reading
Most Popular
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Stay connected
Illustration by Rose WongGet the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.